Gene expression signature associated with survival in advanced ovarian cancer

Feb 03, 2009

A new study published this week in the open-access journal PLoS Medicine identifies molecular pathways associated with outcomes in ovarian cancer. Currently, outcomes following diagnosis of ovarian cancer are very poor, with up to 65-70% of women dying within five years of diagnosis.

Anne Crijns and her colleagues from the University of Groningen in the Netherlands aimed to find out whether the expression levels of particular genes were associated with overall survival in ovarian cancer. The researchers initially studied a series of tissue samples, obtained during surgery to remove cancerous tissue from 157 consecutive patients seen at the University Medical Center Groningen. Analysis of the samples identified 86 genes which correlated with overall survival in the women. The researchers were then able to confirm, for 57 of the 86 genes, that these were also correlated with survival in a second, entirely separate dataset. Specific genes, and pathways, were identified which provide specific targets around which researchers might be able to design potential therapies in future.

For example, Crijns and colleagues find high expression of a gene encoding a FK506 binding protein, FKBP7, is associated with poor prognosis. This protein can be targeted with existing drugs, the mTOR inhibitors. Another implication of the work discussed by the researchers is the use of this expression signature to identify women who are at greater risk of relapse, and thus potentially personalize treatment. However, as the authors acknowledge, such implications are still some way off. It would be important to carry out prospective studies in order to show that the signature performs effectively in a clinical setting.

The new study is discussed in an expert commentary by Simon Gayther and Kate Lawrenson of University College London, who were not involved in the study.

Citation: Crijns APG, Fehrmann RSN, de Jong S, Gerbens F, Meersma GJ, et al. (2009) Survival-related profile, pathways, and transcription factors in ovarian cancer. PLoS Med 6(2): e1000024. doi:10.1371/journal.pmed.1000024
medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.1000024

Source: Public Library of Science

Explore further: Team identifies source of most cases of invasive bladder cancer

add to favorites email to friend print save as pdf

Related Stories

Top US court sifts arguments on software patents

Mar 31, 2014

The US Supreme Court heard arguments Monday on whether patents can be enforced for software-created business practices, in a case likely to have a big impact on the tech sector.

High court ruling on gene patents lifts Myriad

Jun 13, 2013

Shares of diagnostic test maker Myriad Genetics Inc. are jumping Thursday after the Supreme Court issued a mixed ruling in a case involving the company's patents on genes at the center of its tests for increased risk of bre ...

How gold nanoparticles can help fight ovarian cancer

May 21, 2013

Positively charged gold nanoparticles are usually toxic to cells, but cancer cells somehow manage to avoid nanoparticle toxicity. Mayo Clinic researchers found out why, and determined how to make the nanoparticles effective ...

Recommended for you

Cancer stem cells linked to drug resistance

7 hours ago

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

Unraveling the 'black ribbon' around lung cancer

Apr 17, 2014

It's not uncommon these days to find a colored ribbon representing a disease. A pink ribbon is well known to signify breast cancer. But what color ribbon does one think of with lung cancer?

User comments : 0

More news stories

Less-schooled whites lose longevity, study finds

Barbara Gentry slowly shifts her heavy frame out of a chair and uses a walker to move the dozen feet to a chair not far from the pool table at the Buford Senior Center. Her hair is white and a cough sometimes interrupts her ...

Cancer stem cells linked to drug resistance

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

Making graphene in your kitchen

Graphene has been touted as a wonder material—the world's thinnest substance, but super-strong. Now scientists say it is so easy to make you could produce some in your kitchen.